Mereo is a new UK-based speciality biopharmaceutical company.
Mereo Biopharma has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
Mereo Biopharma's investors include Vivo Capital, Janus Henderson Investors, Perceptive Advisors, Samsara BioCapital, Rock Springs Capital.
Mereo Biopharma is headquartered in London, United Kingdom.
Mereo is a new UK-based speciality biopharmaceutical company.
Mereo Biopharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mereo Biopharma — Funding & Investors." VCBacked, June 14, 2024, https://www.vcbacked.co/company/mereo-biopharma. Accessed August 16, 2026.
VCBacked. (2024). Mereo Biopharma — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/mereo-biopharma
{{cite web |title=Mereo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/mereo-biopharma |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated